Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (opens in new window).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
TARO-TADALAFIL SUN PHARMA CANADA INC Resolved 5MG Updated Report 2026-01-20 271688
TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE TARO PHARMACEUTICALS INC Actual shortage 0.05% 1% Updated Report 2026-01-20 274305
TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT TARO PHARMACEUTICALS INC Actual shortage 5% 1% Updated Report 2026-01-20 273596
MYXREDLIN BAXTER CORPORATION Actual shortage 1UNIT Updated Report 2026-01-20 272638
AURO-ARIPIPRAZOLE AURO PHARMA INC Actual shortage 30MG Updated Report 2026-01-20 226448
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE OMEGA LABORATORIES LIMITED Actual shortage 2MG Updated Report 2026-01-20 275298
ARSENIC TRIOXIDE FOR INJECTION STERIMAX INC Actual shortage 1MG Updated Report 2026-01-20 235163
MYLAN-ALMOTRIPTAN MYLAN PHARMACEUTICALS ULC Actual shortage 12.5MG Updated Report 2026-01-20 273789
IXCHIQ VALNEVA AUSTRIA GMBH Resolved 3Log10 TCID50 Updated Report 2026-01-20 272806
ABRILADA PFIZER CANADA ULC Anticipated shortage 20MG Updated Report 2026-01-19 276355
!!T3 IFEX BAXTER CORPORATION Actual shortage 1G Updated Report 2026-01-19 273126
!!T3 IFEX BAXTER CORPORATION Actual shortage 3G Updated Report 2026-01-19 273129
METADOL ENDO OPERATIONS LTD. Actual shortage 1MG Updated Report 2026-01-19 273380
DETROL LA BGP PHARMA ULC Actual shortage 2MG Updated Report 2026-01-19 275958
DETROL LA BGP PHARMA ULC Actual shortage 4MG Updated Report 2026-01-19 269462
ANDROGEL BGP PHARMA ULC Anticipated shortage 12.5MG Updated Report 2026-01-19 275975
LYRICA BGP PHARMA ULC Anticipated shortage 50MG Updated Report 2026-01-19 274414
NEURONTIN BGP PHARMA ULC Anticipated shortage 400MG Updated Report 2026-01-19 275980
VIAGRA BGP PHARMA ULC Anticipated shortage 25MG Updated Report 2026-01-19 275983
VIAGRA BGP PHARMA ULC Anticipated shortage 50MG New Report 2026-01-19 276332

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
BENZAMYCIN BAUSCH HEALTH, CANADA INC. To be discontinued 3% 5% New Report 2026-01-20 276371
PAXIL TAB 30MG GLAXOSMITHKLINE INC To be discontinued 30MG Updated Report 2026-01-19 224430
XULTOPHY NOVO NORDISK CANADA INC Discontinued 3.6MG 100UNIT Updated Report 2026-01-14 240243
SYNPHASIC 28 TABLETS PFIZER CANADA ULC To be discontinued 0.5MG 1.0MG 0.035MG 0.035MG New Report 2026-01-13 275994
FLAMAZINE SMITH & NEPHEW INC Discontinued 1% Updated Report 2026-01-12 263349
CANCIDAS MERCK CANADA INC To be discontinued 50MG Updated Report 2026-01-08 273084
SANDOZ AMPHETAMINE XR SANDOZ CANADA INCORPORATED Discontinued 15MG New Report 2026-01-08 275341
NAT-ESCITALOPRAM NATCO PHARMA (CANADA) INC Discontinued 20MG New Report 2026-01-06 275279
NAT-ESCITALOPRAM NATCO PHARMA (CANADA) INC Discontinued 10MG New Report 2026-01-06 275276
EMEND TRI-PACK MERCK CANADA INC To be discontinued 80MG 125MG New Report 2026-01-05 275233
EMEND MERCK CANADA INC To be discontinued 125MG New Report 2026-01-05 275223
EMEND MERCK CANADA INC To be discontinued 80MG New Report 2026-01-05 275220
NOVOLIN GE 30/70 PENFILL NOVO NORDISK CANADA INC To be discontinued 70UNIT 30UNIT Updated Report 2026-01-05 240237
LEVEMIR PENFILL NOVO NORDISK CANADA INC To be discontinued 100UNIT Updated Report 2026-01-05 240231
HYPURIN REGULAR INSULIN PORK WOCKHARDT UK LIMITED Discontinued 100UNIT Updated Report 2026-01-01 255200
CUBICIN RF CUBIST PHARMACEUTICALS LLC To be discontinued 500MG Updated Report 2025-12-30 266775
HUMATROPE ELI LILLY CANADA INC Discontinued 6MG 3.15ML Updated Report 2025-12-24 240676
HUMATROPE ELI LILLY CANADA INC Discontinued 12MG 3.15ML Updated Report 2025-12-24 240679
HUMATROPE ELI LILLY CANADA INC Discontinued 24MG 3.15ML Updated Report 2025-12-24 240682
EMERADE BAUSCH HEALTH, CANADA INC. Discontinued 0.5MG Updated Report 2025-12-20 274745
Get it on Google Play Download on the App Store